WDC
OCUL icon

Woodward Diversified Capital’s Ocular Therapeutix OCUL Stock Holding History

Woodward Diversified Capital’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$110K Hold
11,200
– – 0.05% 177
2025
Q4 		$136K Hold
11,200
– – 0.06% 181
2025
Q3 		$131K Hold
11,200
– – 0.06% 179
2025
Q2 		$104K Hold
11,200
– – 0.05% 169
2025
Q1 		$82.1K Hold
11,200
– – 0.06% 133
2024
Q4 		$95.6K Hold
11,200
– – 0.07% 129
2024
Q3 		$97.4K Hold
11,200
– – 0.06% 158
2024
Q2 		$76.6K Buy
+11,200
New +$69.1K 0.04% 158

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Woodward Diversified Capital's OCUL Position: Q1 2026 in Review

Woodward Diversified Capital held its Ocular Therapeutix (OCUL) position steady in Q1 2026 at 11,200 shares worth $110K. The position accounts for 0.05% of the portfolio, ranked #177.

Woodward Diversified Capital first reported a position in OCUL in Q2 2024 and has held it in 8 quarters since. The position peaked at $136K in Q4 2025. 269 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

  • Woodward Diversified Capital held 11,200 shares of Ocular Therapeutix worth $110K as of Q1 2026.
  • Woodward Diversified Capital left its Ocular Therapeutix share count unchanged in Q1 2026.
  • Ocular Therapeutix made up 0.05% of Woodward Diversified Capital's portfolio in Q1 2026, its #177 holding.
  • Woodward Diversified Capital first reported a position in Ocular Therapeutix in Q2 2024 and has held it in 8 quarters since.
  • Woodward Diversified Capital's Ocular Therapeutix position peaked at $136K in Q4 2025.
  • 269 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Woodward Diversified Capital's 13F filing for Q1 2026, filed 24 Apr 2026.